The chemists of the “Metal complexes and MRI” research group have developed novel imaging probes which specifically recognise amyloid aggregates, characteristic of Alzheimer’s Disease and Diabetes and gained new insights into their peptide binding mechanisms. These results could facilitate early diagnosis and better molecular understanding of these diseases.
A lire aussi
July 19, 2024 - Thibault Fillion's thesis defense
12 July 2024
par Isabelle Frapart
Software is ubiquitous in science, yet overlooked
11 July 2024
par Isabelle Frapart
Protein filaments in the regulation of gene expression
05 July 2024
par Isabelle Frapart